Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 61 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ENGOT-en11/GOG-3053/KEYNOTE-B21: a Randomised, Double-Blind, Phase III Study of Pembrolizumab or Placebo Plus Adjuvant Chemotherapy with or Without Radiotherapy in Patients with Newly Diagnosed, High-Risk Endometrial Cancer
T Van Gorp, D Cibula, W Lv, F Backes, F Ortaç, K Hasegawa, K Lindemann,A Savarese, A Laenen, Y M Kim, L Bodnar,M-P Barretina-Ginesta, L Gilbert, B Pothuri, X Chen, M B Flores, T Levy, N Colombo, C Papadimitriou, T Buchanan, L C Hanker, G Eminowicz, L Rob, D Black, J Lichfield, G Lin, R Orlowski, S Keefe, A Lortholary, B Slomovitz, ENGOT-en1GOG-KEYNOTE-B2 investigators
Annals of oncology official journal of the European Society for Medical Oncology（2024）
Cited0Views0WOSBibtex
0
0
Niraparib First-Line Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian Cancer: Final Overall Survival Results from PRIMA/ENGOT-OV26/GOG-3012 Trial
B.J. Monk,M.P. Barretina-Ginesta, B. Pothuri, I. Vergote,W. Graybill, M.R. Mirza, C.C. McCormick, D. Lorusso, R.G. Moore, G. Freyer,R.E. O’Cearbhaill, F. Heitz,D.M. O’Malley,A. Redondo, M.S. Shahin,C. Vulsteke, W.H. Bradley,C.A. Haslund,D.M. Chase, C. Pisano
Annals of Oncology (2024)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 61

#Citation: 1372

H-Index: 9

G-Index: 26

Sociability: 6

Diversity: 2

Activity: 28

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn